About G/T mismatch-specific thymine DNA glycosylase
G/T mismatch-specific thymine DNA glycosylase (TDG) is a protein
from Homo sapiens identified by UniProt accession
Q13569, 410 residues long.
MolForge cross-references it against 0 known binders and
117 disease associations.
Target properties
| Protein name | G/T mismatch-specific thymine DNA glycosylase |
| UniProt accession | Q13569 |
| Gene | TDG |
| Organism | Homo sapiens |
| Length | 410 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (117)
Diseases linked to this target (Open Targets).
- low grade glioma · score 0.25
- ovarian cancer · score 0.23
- body height · score 0.23
- glioblastoma multiforme · score 0.20
- esophageal cancer · score 0.14
- cor pulmonale · score 0.13
- BMI-adjusted waist circumference · score 0.12
- central corneal thickness · score 0.12
- hereditary breast ovarian cancer syndrome · score 0.12
- Hereditary breast and ovarian cancer syndrome · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13569-F1 | alphafold | PREDICTED | 70.20 | — |
Amino-acid sequence (410 residues)
MEAENAGSYS LQQAQAFYTF PFQQLMAEAP NMAVVNEQQM PEEVPAPAPA QEPVQEAPKG RKRKPRTTEP KQPVEPKKPV ESKKSGKSAK SKEKQEKITD TFKVKRKVDR FNGVSEAELL TKTLPDILTF NLDIVIIGIN PGLMAAYKGH HYPGPGNHFW KCLFMSGLSE VQLNHMDDHT LPGKYGIGFT NMVERTTPGS KDLSSKEFRE GGRILVQKLQ KYQPRIAVFN GKCIYEIFSK EVFGVKVKNL EFGLQPHKIP DTETLCYVMP SSSARCAQFP RAQDKVHYYI KLKDLRDQLK GIERNMDVQE VQYTFDLQLA QEDAKKMAVK EEKYDPGYEA AYGGAYGENP CSSEPCGFSS NGLIESVELR GESAFSGIPN GQWMTQSFTD QIPSFSNHCG TQEQEEESHA
Explore G/T mismatch-specific thymine DNA glycosylase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets